Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Beta Drugs Share Price

Beta Drugs Ltd.

₹1,293

-19.70(-1.50%)

Trade Now

28th Apr 2026 | 3:28 PM

NSE : BETA

Open Free Demat Account

Beta Drugs Performance

Price Movement

₹1293.00

₹1275.00

₹1345.00

↘ Today's Low↗ Today's High

1 Year Performance

₹1293.00

₹990.10

₹2000.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,345.00

Low₹1,275.00

Open at₹1,312.70

Prev Close₹1,312.70

Volumes7.39 K

Avg Price₹1,318.03

Lower Circuit₹1,050.20

Upper Circuit₹1,575.20

Historical Performance

3M High₹1,664.60

3M Low₹990.10

1 Yr High₹2,000.00

1 Yr Low₹990.10

3 Yr High₹2,215.24

3 Yr Low₹628.57

5 Yr High₹2,215.24

5 Yr Low₹167.62

Beta Drugs Fundamentals

Market Cap

Above industry Median

1,314.60 Cr.

PE Ratio (TTM)

Above industry Median

31.70

Dividend Yield

Net Profit TTM

41.47

Net Profit Growth

41.47

PEG Ratio

ROE

7% decr over last year

21.52

Operating Revenue TTM

384.62

Operating Revenue Growth

Book Value

Above industry Median

5.70

MFI

MFI is mid-range

43.97

RSI

RSI is mid-range

50.78

EPS (TTM)

42.02

Debt to Equity

0.67

Face Value

Operating Profit Margin Qtr.

20.23

Operating Profit Qtr.

16.99

Net Profit Qtr.

8.52

Operating Revenue Qtr.

87.27

PB Ratio

5.70

Beta Drugs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	50.28	54.48	66.32	53.74	48.27
Operating Expense	43.73	49.75	58.82	48.49	42.55
Operating Profit	6.55	4.73	7.51	5.25	5.72
Depreciation	2.51	2.38	2.04	2.14	1.92
Interest	3.17	2.97	2.79	2.81	1.33
Tax	0.12	0.61	1.42	0.62	0.25
Net Profit	3.25	1.51	4.23	1.39	0.75

Beta Drugs Technicals

Beta Drugs Ltd. EMA & SMA

₹1293.00

-19.70 (-1.50%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1329.2

Day EMA10 ₹1339.3

Day EMA12 ₹1338.2

Day EMA20 ₹1321

Day EMA26 ₹1308.2

Day EMA50 ₹1304.7

Day EMA100 ₹1382.7

Day EMA200 ₹1500.8

Beta Drugs Support and Resistance

Resistance

First Resistance₹1337.47

Second Resistance₹1362.23

Third Resistance₹1380.47

Support

First Support₹1294.47

Second Support₹1276.23

Third Support₹1251.47

Technical Indicators

Day RSI50.78

Day MFI43.97

Day ADX27.71

Day Commodity Channel Index-31.80

William-96.33

Day MACD29.99

Day MACD Signal Line42.90

Day ATR87.60

Day ROC125-27.89

Day ROC2122.94

Beta Drugs Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	66.7	66.7	66.7	66.7	64.9	64.6
FII	1.2	0.9	0.9	0.9	1.1	1.2
DII	0.1	0.2	0.3	0.3	1.9	2.1
Public	31.9	32.2	32.1	32.1	32.1	32

Beta Drugs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	3.57 K	5.42 K	65.90%
Week	5.01 K	9.31 K	53.87%
1 Month	6.31 K	13.25 K	47.61%
6 Month	6.96 K	11.04 K	63.00%

Beta Drugs SWOT Analysis

Strengths8

Weakness11

Opportunity1

Threats0

Benjamin Graham Value Screen

Relative Outperformance versus Industry over 1 Month

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Beta Drugs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Beta Drugs Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Medistep Healthcare Ltd.
Price (₹)	₹488.90	₹6.85	₹120.05	₹133.70	₹13.20	₹20.90
% Change	0.76%	-0.44%	3.49%	-0.69%	-7.89%	4.76%
Revenue TTM (₹ Cr)	-	₹83.60	-	₹282.74	-	-
Net Profit TTM (₹ Cr)	-	₹-34.95	-	₹15.30	-	-
PE TTM	-	-1.60	15.90	33.60	-	7.20
1 Year Return	23.1	594	-6.25	5.06	45.05	-51.4
ROCE	28.91	-5.63	-	-	-	-

Similar Stocks

INFLUX

Influx Healthtech Ltd.

₹ 249.00

-0.92%

MEDIORG

Medicamen Organics Ltd.

₹ 30.05

+2.91%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 582.05

+0.36%

SENORES

Senores Pharmaceuticals Ltd.

₹ 915.00

-2.63%

INNOVACAP

Innova Captab Ltd.

₹ 723.15

+0.71%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 80.00

+5.42%

SIGACHI

Sigachi Industries Ltd.

₹ 20.30

WINDLAS

Windlas Biotech Ltd.

₹ 852.50

-1.73%

VINEETLAB

Vineet Laboratories Ltd.

₹ 36.00

-5.44%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 479.60

-0.77%

ZIMLAB

Zim Laboratories Ltd.

₹ 84.12

-2.33%

MEDICO

Medico Remedies Ltd.

₹ 40.17

-2.43%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 184.50

+5.55%

LASA

Lasa Supergenerics Ltd.

₹ 8.13

+0.49%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 342.00

+3.46%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 323.05

-2.64%

ORTINGLOBE

Ortin Global Ltd.

₹ 15.70

+3.49%

BROOKS

Brooks Laboratories Ltd.

₹ 61.50

-4.59%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2036.90

+1.25%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 132.97

-0.42%

ALPA

Alpa Laboratories Ltd.

₹ 68.30

-0.01%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 147.00

+0.19%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 392.00

-1.91%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.60

+0.32%

FAQ's on BETA

What is the Market Capitalization of Beta Drugs Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Beta Drugs Ltd. is approximately ₹ 1314.6 Cr.

What are the PE and PB ratios for Beta Drugs Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Beta Drugs Ltd. is 31.7, and the Price-to-Book (PB) ratio is 5.7.

What is the 52-Week High and Low for Beta Drugs Ltd.?

Over the past 52 weeks, the highest price reached by Beta Drugs Ltd. shares was ₹ 2000, and the lowest price was ₹ 990.1.

Who are the major shareholders of Beta Drugs Ltd.?

Significant shareholdings in Beta Drugs Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Beta Drugs Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Beta Drugs Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.